Cargando…
SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes
NADPH oxidase (NOX)-derived oxidative stress is an important factor in renal progression, with NOX4 being the predominant NOX in the kidney. Recently, Src homology 3 (SH3) domain-containing YSC84-like 1 (SH3YL1) was reported to be a regulator of NOX4. In this study, we tested whether the SH3YL1 prot...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141384/ https://www.ncbi.nlm.nih.gov/pubmed/37109492 http://dx.doi.org/10.3390/life13040963 |
_version_ | 1785033374740512768 |
---|---|
author | Han, Sang Youb Han, Seung Hyun Ghee, Jung Yeon Cha, Jin Joo Kang, Young Sun Cha, Dae Ryong |
author_facet | Han, Sang Youb Han, Seung Hyun Ghee, Jung Yeon Cha, Jin Joo Kang, Young Sun Cha, Dae Ryong |
author_sort | Han, Sang Youb |
collection | PubMed |
description | NADPH oxidase (NOX)-derived oxidative stress is an important factor in renal progression, with NOX4 being the predominant NOX in the kidney. Recently, Src homology 3 (SH3) domain-containing YSC84-like 1 (SH3YL1) was reported to be a regulator of NOX4. In this study, we tested whether the SH3YL1 protein could predict 3-year renal outcomes in patients with type 2 diabetes. A total of 131 patients with type 2 diabetes were enrolled in this study. Renal events were defined as a 15% decline in the estimated glomerular filtration rate (eGFR) from the baseline, the initiation of renal replacement therapy, or death during the 3 years. The levels of the urinary SH3YL1-to-creatinine ratio (USCR) were significantly different among the five stages of chronic kidney disease (CKD) and the three groups, based on albuminuria levels. The USCR levels showed a significant negative correlation with eGFR and a positive correlation with the urinary albumin-to-creatinine ratio (UACR). Plasma SH3YL1 levels were significantly correlated with UACR. The highest tertile group of USCR and plasma SH3YL1 had a significantly lower probability of renal event-free survival. Furthermore, the highest tertile group of USCR showed a significant association with the incidence of renal events after full adjustment: adjusted hazard ratio (4.636: 95% confidence interval, 1.416–15.181, p = 0.011). This study suggests that SH3YL1 is a new diagnostic biomarker for renal outcomes in patients with type 2 diabetes. |
format | Online Article Text |
id | pubmed-10141384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101413842023-04-29 SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes Han, Sang Youb Han, Seung Hyun Ghee, Jung Yeon Cha, Jin Joo Kang, Young Sun Cha, Dae Ryong Life (Basel) Article NADPH oxidase (NOX)-derived oxidative stress is an important factor in renal progression, with NOX4 being the predominant NOX in the kidney. Recently, Src homology 3 (SH3) domain-containing YSC84-like 1 (SH3YL1) was reported to be a regulator of NOX4. In this study, we tested whether the SH3YL1 protein could predict 3-year renal outcomes in patients with type 2 diabetes. A total of 131 patients with type 2 diabetes were enrolled in this study. Renal events were defined as a 15% decline in the estimated glomerular filtration rate (eGFR) from the baseline, the initiation of renal replacement therapy, or death during the 3 years. The levels of the urinary SH3YL1-to-creatinine ratio (USCR) were significantly different among the five stages of chronic kidney disease (CKD) and the three groups, based on albuminuria levels. The USCR levels showed a significant negative correlation with eGFR and a positive correlation with the urinary albumin-to-creatinine ratio (UACR). Plasma SH3YL1 levels were significantly correlated with UACR. The highest tertile group of USCR and plasma SH3YL1 had a significantly lower probability of renal event-free survival. Furthermore, the highest tertile group of USCR showed a significant association with the incidence of renal events after full adjustment: adjusted hazard ratio (4.636: 95% confidence interval, 1.416–15.181, p = 0.011). This study suggests that SH3YL1 is a new diagnostic biomarker for renal outcomes in patients with type 2 diabetes. MDPI 2023-04-07 /pmc/articles/PMC10141384/ /pubmed/37109492 http://dx.doi.org/10.3390/life13040963 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Han, Sang Youb Han, Seung Hyun Ghee, Jung Yeon Cha, Jin Joo Kang, Young Sun Cha, Dae Ryong SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes |
title | SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes |
title_full | SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes |
title_fullStr | SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes |
title_full_unstemmed | SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes |
title_short | SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes |
title_sort | sh3yl1 protein predicts renal outcomes in patients with type 2 diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141384/ https://www.ncbi.nlm.nih.gov/pubmed/37109492 http://dx.doi.org/10.3390/life13040963 |
work_keys_str_mv | AT hansangyoub sh3yl1proteinpredictsrenaloutcomesinpatientswithtype2diabetes AT hanseunghyun sh3yl1proteinpredictsrenaloutcomesinpatientswithtype2diabetes AT gheejungyeon sh3yl1proteinpredictsrenaloutcomesinpatientswithtype2diabetes AT chajinjoo sh3yl1proteinpredictsrenaloutcomesinpatientswithtype2diabetes AT kangyoungsun sh3yl1proteinpredictsrenaloutcomesinpatientswithtype2diabetes AT chadaeryong sh3yl1proteinpredictsrenaloutcomesinpatientswithtype2diabetes |